Skip to main content
. 2014 Jan 22;15(1):6. doi: 10.1186/1465-9921-15-6

Table 4.

Microbiological diagnosis

Microbiological diagnosis, n [patients with a positive microbiological diagnosis] (%) Early responders n = 332 Later responders n = 253 Patients without Halm-based assessment of TCS n = 1454
Number of patients with a microbiological diagnosis
87 (26.2)
87 (34.4)
408 (28.1)
Gram-positive cocci*
40 (46.0)
38 (43.7)
208 (51.0)
Streptococcus pneumoniae
32 (36.8)
28 (32.2)
168 (41.2)
 Penicillin-resistant Streptococcus pneumoniae
0
1 (1.1)
1 (0.2)
 Methicillin-resistant Staphylococcus aureus
0
1 (1.1)
11 (2.7)
 Methicillin-susceptible Staphylococcus aureus
9 (10.3)
9 (10.3)
33 (8.1)
Legionella spp.
4 (4.6)
3 (3.4)
13 (3.2)
Mycoplasma pneumoniae
4 (4.6)
1 (1.1)
13 (3.2)
Chlamydophila pneumoniae
0
2 (2.3)
11 (2.7)
Gram-negative bacilli
15 (17.2)
11 (12.6)
81 (19.8)
Haemophilus influenzae
7 (8.0)
3 (3.4)
23 (5.6)
Haemophilus parainfluenzae
3 (3.4)
1 (1.1)
2 (0.5)
Moraxella catarrhalis
2 (2.3)
0
7 (1.7)
Pseudomonas aeruginosa
4 (4.6)
8 (9.2)
29 (7.1)
Escherichia coli
4 (4.6)
3 (1.4)
29 (7.1)
Klebsiella spp.
2 (2.3)
0
17 (4.2)
Aspiration pneumonia§
1 (1.1)
4 (4.6)
12 (2.9)
Other microorganisms
19 (21.8)
32 (36.8)
82 (20.1)
Unknown (not identified) 248 (74.7) 167 (66.0) 1060 (72.9)

*Includes other Streptococcus spp. and Staphylococcus spp.

Includes Morganella morganii, Pasteurella multocida, Proteus mirabilis and Serratia marcescens, Acinetobacter spp. and Hafnia alvei.

§Commonly applied to situations when a patient with risk factors for aspiration presents with pneumonia.